RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Sensyne Health Stock

Sensyne Health Revenue 2024

Sensyne Health Revenue

75.76 M GBP

Ticker

SENS.L

ISIN

GB00BYV3J755

WKN

A2N38D

In 2024, Sensyne Health's sales reached 75.76 M GBP, a 40.13% difference from the 54.06 M GBP sales recorded in the previous year.

The Sensyne Health Revenue history

YEARREVENUE (undefined GBP)GROSS MARGIN (%)
2026e143.634,11
2025e1145,18
2024e75.767,80
2023e54.0610,93
2022e27.2421,70
20219.164,95
20202.0556,59
20190.14-28,57
20180.08-137,50

Sensyne Health Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Sensyne Health, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Sensyne Health from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Sensyne Health’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Sensyne Health. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Sensyne Health’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Sensyne Health’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Sensyne Health’s growth potential.

Sensyne Health Revenue, EBIT and net profit per share

DateSensyne Health RevenueSensyne Health EBITSensyne Health Net Income
2026e143.63 M undefined76.92 M undefined756.09 undefined
2025e114 M undefined43.25 M undefined1,360.19 undefined
2024e75.76 M undefined24.56 M undefined2,471.43 undefined
2023e54.06 M undefined10.02 M undefined100,471.27 undefined
2022e27.24 M undefined-9.07 M undefined-92,418.1 undefined
20219.1 M undefined-26.91 M undefined-27.52 M undefined
20202.05 M undefined-21.04 M undefined-21.84 M undefined
2019140,000 undefined-15.67 M undefined-21.93 M undefined
201880,000 undefined-7.25 M undefined-49.84 M undefined

Sensyne Health stock margins

The Sensyne Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Sensyne Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Sensyne Health.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Sensyne Health's sales revenue. A higher gross margin percentage indicates that the Sensyne Health retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Sensyne Health's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Sensyne Health's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Sensyne Health's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Sensyne Health. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Sensyne Health's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Sensyne Health Margin History

Sensyne Health Gross marginSensyne Health Profit marginSensyne Health EBIT marginSensyne Health Profit margin
2026e64.95 %53.56 %0 %
2025e64.95 %37.94 %0 %
2024e64.95 %32.42 %0 %
2023e64.95 %18.53 %0.19 %
2022e64.95 %-33.29 %-0.34 %
202164.95 %-295.71 %-302.42 %
202056.59 %-1,026.34 %-1,065.37 %
2019-28.57 %-11,192.86 %-15,664.29 %
2018-137.5 %-9,062.5 %-62,300 %

Sensyne Health Aktienanalyse

What does Sensyne Health do?

Sensyne Health PLC is a British company specializing in artificial intelligence (AI) and digital health solutions. It was founded in 2018 and is headquartered in Oxford, UK. History: Sensyne Health was founded by Lord Drayson, a British entrepreneur and former Minister for Science and Innovation. The company is based on the belief that the application of AI technologies in the healthcare industry can help improve medical care, make the healthcare system more efficient, and ultimately save lives. Business model: Sensyne Health offers a range of products and services based on AI technologies. The key business areas include: - Clinical research: Sensyne Health works closely with national health authorities and various hospitals to collect and analyze data that can be used in the development of new treatment options and the improvement of diagnostic processes. - Digital patient monitoring: The company develops advanced sensors and devices that allow doctors and nurses to monitor the health status of patients in real-time. By using AI algorithms, health problems can be detected and treated early. - AI-based analysis: Sensyne Health has extensive experience in applying AI technologies to medical data. The company uses its expertise to conduct complex data analysis that helps doctors and researchers gain new insights into diseases and their treatment options. Products: Sensyne Health offers a variety of products and solutions tailored to the needs of the healthcare industry. Here are some of the key products that the company offers: - Patient data platform: A cloud-based platform that allows hospitals and research institutions to collect, store, and analyze patient data. The use of AI algorithms automates and accelerates data analysis. - Hospital collaborations: Sensyne Health works with various hospitals in the UK and other countries to collect and analyze patient data. The data is then shared in anonymized form with researchers and life science companies to develop new insights and treatment options. - AI-based patient monitoring: Sensyne Health has developed a range of devices and sensors that allow doctors and nurses to monitor the health status of patients in real-time. The data is automatically evaluated, and the results are transmitted to the medical staff to quickly respond to changes in the patient's condition. Conclusion: Sensyne Health is a leading provider of AI-based solutions for the healthcare industry. The company specializes in data collection, analysis, and the development of new treatment options. Through its collaborations with hospitals and government agencies, Sensyne Health has access to a large amount of data that can lead to new insights and improve medical care in the future. Answer: Sensyne Health PLC is a British company specializing in artificial intelligence (AI) and digital health solutions. It was founded in 2018 and is headquartered in Oxford, UK. The company was founded by Lord Drayson, and it aims to use AI technologies to improve medical care, make healthcare more efficient, and save lives. Sensyne Health offers products and services in clinical research, digital patient monitoring, and AI-based analysis. The company's products include a patient data platform, collaborations with hospitals, and AI-based patient monitoring devices. Sensyne Health is focused on collecting and analyzing data to develop new treatment options and improve healthcare in the future. Sensyne Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Sensyne Health's Sales Figures

The sales figures of Sensyne Health originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Sensyne Health’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Sensyne Health's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Sensyne Health’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Sensyne Health stock

How much revenue did Sensyne Health generate this year?

Sensyne Health has achieved a revenue of 75.76 M GBP this year.

How much was the turnover of the company Sensyne Health compared to the previous year?

The revenue of Sensyne Health has increased by 40.13% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Sensyne Health?

The revenue of Sensyne Health is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Sensyne Health measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Sensyne Health so important for investors?

The revenue of Sensyne Health is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Sensyne Health pay?

Over the past 12 months, Sensyne Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sensyne Health is expected to pay a dividend of 0 GBP.

What is the dividend yield of Sensyne Health?

The current dividend yield of Sensyne Health is .

When does Sensyne Health pay dividends?

Sensyne Health pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sensyne Health?

Sensyne Health paid dividends every year for the past 0 years.

What is the dividend of Sensyne Health?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sensyne Health located?

Sensyne Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sensyne Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sensyne Health from 12/12/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 12/12/2024.

When did Sensyne Health pay the last dividend?

The last dividend was paid out on 12/12/2024.

What was the dividend of Sensyne Health in the year 2023?

In the year 2023, Sensyne Health distributed 0 GBP as dividends.

In which currency does Sensyne Health pay out the dividend?

The dividends of Sensyne Health are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sensyne Health

Our stock analysis for Sensyne Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sensyne Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.